Trial intelligence / Profile preview

Compound Cydiodine Buccal Tablets in Recurrent Aphthous Ulcer

CTR20221596Phase 2Completed

Sponsor
Renfu Junwei
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cydiodine in aphthosis (RAS), sponsored by Renfu Junwei. Started Jun 2022; status: completed.

02

Drugs

cydiodine
03

Conditions

aphthosis (RAS)

Beyond the preview

Go deeper on CTR20221596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20221596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call